The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Primary Ficolin-3 deficiency – Is it associated with increased susceptibility to infections?
Abstract
Ficolin-3 (also called H-ficolin or Hakata antigen) is the most potent activator of the lectin pathway of complement in vitro. Its genetically determined deficiency in Caucasians is associated with a frame-shift mutation +1637delC (rs28357092) of the FCN3 gene. When it was described for the first time, it was postulated to be strictly associated with enhanced susceptibility to infections. At present, with our knowledge extended by several other patients that issue seems to be more complicated and less clear-cut. Two new cases of primary Ficolin-3 deficiency are reported here: a 50-year old male, suffering from membranous nephropathy and an 11-month old male infant who was operated on to repair congenital heart disease. Based on those cases and a literature review, we conclude that the clinical consequences of congenital Ficolin-3 deficiency are still unclear and such questions as whether it may be life-threatening or acts as a disease modifier remain to be elucidated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the trans pQTL at FCN3 is a low-frequency frameshift variant (rs532781899, MAF = 1.4%) leading to FCN3 deficiency [44][45][46] and, here, to reduced MASP1 levels (β = -1.16,P = 3.8 × 10 -312 )”
From Plasma proteomic associations with genetics and health in the UK Biobank (2023) · cites this paper as [44]
Citations
Cites
Sugimoto, R., Yae, Y., Akaiwa, M., Kitajima, S., Shibata, Y., Sato, H., Hirata, J., Okochi, K., Izuhara, K., & Hamasaki, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.20721 · Cited by 207
Immunodeficiency Associated with FCN3 Mutation and Ficolin-3 Deficiency
Munthe-Fog, L., Hummelshøj, T., Honoré, C., Madsen, H. O., Permin, H., & Garred, P. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900381 · Cited by 172
Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen)
Hummelshøj, T., Munthe‐Fog, L., MADSEN, H. O., Sim, R. B., & Garred, P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.006 · Cited by 134
Munthe‐Fog, L., Hummelshøj, T., Ma, Y. J., Hansen, B. E., Koch, C., MADSEN, H. O., Skjødt, K., & Garred, P. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.12.012 · Cited by 131
Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis
Schlapbach, L. J., Thiel, S., Kessler, U., Ammann, R. A., Aebi, C., & Jensenius, J. C. (2011) · Gut · doi:10.1136/gut.2010.226027 · Cited by 57
Tsujimura, M., Miyazaki, T., Kojima, E., Sagara, Y., Shiraki, H., OKOCHI, K., & Maeda, Y. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00274-7 · Cited by 48
H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates
Michalski, M., Szala, A., St. Swierzko, A., Lukasiewicz, J., Maciejewska, A., Kilpatrick, D. C., Matsushita, M., Domzalska-Popadiuk, I., Borkowska-Klos, M., Sokolowska, A., et al. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.12.004 · Cited by 41
Self-citationInaba, S., OKOCHI, K., Yae, Y., Niklasson, F., & de Verder, C. H. (1990) · PubMed · Cited by 31
Ficolin-3 activity towards the opportunistic pathogen, Hafnia alvei
Michalski, M., Świerzko, A. S., Łukasiewicz, J., Man-Kupisinska, A., Karwaciak, I., Przygodzka, P., & Cedzyński, M. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.08.012 · Cited by 28
Self-citationFukutomi, T., Ando, B., Sakamoto, S., Sakai, H., & Nawata, H. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(96)06393-0 · Cited by 16
Cited by
Plasma proteomic associations with genetics and health in the UK Biobank
Sun, B. B., Chiou, J., Traylor, M., Benner, C., Hsu, Y.-H., Richardson, T. G., Surendran, P., Mahajan, A., Robins, C., Vasquez-Grinnell, S. G., et al. (2023) · Nature · doi:10.1038/s41586-023-06592-6 · Cited by 1,880
“%) leading to FCN3 deficiency 44–46 and, here, to reduced MASP1 levels ( β = −1.16, P = 3.8 × 10 −312 ).”
InfluentialGenetic regulation of the human plasma proteome in 54,306 UK Biobank participants
Sun, B. B., Chiou, J., Traylor, M., Benner, C., Hsu, Y.-H., Richardson, T. G., Surendran, P., Mahajan, A., Robins, C., Vasquez-Grinnell, S. G., et al. (2022) · doi:10.1101/2022.06.17.496443 · Cited by 1,833
A journey through the lectin pathway of complement—MBL and beyond
Garred, P., Genster, N., Pilely, K., Bayarri‐Olmos, R., Rosbjerg, A., Ma, Y. J., & Skjoedt, M. (2016) · Immunological Reviews · doi:10.1111/imr.12468 · Cited by 400
Molecular Pathogenesis of Membranous Nephropathy
Ronco, P. M., & Dêbiec, H. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043811 · Cited by 135
Schröder–Braunstein, J., & Kirschfink, M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.08.002 · Cited by 95
Update on IgG4-mediated autoimmune diseases: New insights and new family members
Koneczny, I. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102646 · Cited by 88
The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus
Troldborg, A., Thiel, S., Trendelenburg, M., Friebus‐Kardash, J., Nehring, J., Steffensen, R., Hansen, S., Laska, M. J., Deleuran, B. W., Jensenius, J. C., et al. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.171033 · Cited by 57
The relationship of circulating proteins in early pregnancy with preterm birth
Lynch, A. M., Wagner, B. D., Deterding, R. R., Giclas, P. C., Gibbs, R. S., Janoff, E. N., Holers, V. M., & Santoro, N. F. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.001 · Cited by 55
Caron, B., Patin, É., Rotival, M., Charbit, B., Albert, M. L., Quintana‐Murci, L., Duffy, D., Rausell, A., Abel, L., Alcover, A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01032-y · Cited by 46
The complement system: A key player in the host response to infections
Jayaraman, A., Walachowski, S., & Bosmann, M. (2024) · European Journal of Immunology · doi:10.1002/eji.202350814 · Cited by 45
Unmet challenges in membranous nephropathy
Salant, D. J. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000459 · Cited by 38
Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway
García-Laorden, M. I., Hernández-Brito, E., Muñoz‐Almagro, C., Nesic, S. P., Rúa‐Figueroa, Í., Briones, M. L., Rajas, O., Borderías, L., Payeras, A., Lorente, L., et al. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00714-4 · Cited by 33
“Five additional patients with a rather heterogeneous range of clinical manifestations and a healthy control were later found by chance in association studies to have genetically proven ficolin-3 deficiency [51, 52]; a role as a predisposing factor for SLE was recently suggested [52].”
BackgroundTroldborg, A., Steffensen, R., Trendelenburg, M., Hauser, T., Winther, K. G., Hansen, A. G., Stengaard‐Pedersen, K., Voss, A., & Thiel, S. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00627-2 · Cited by 29
Genetic Basis of Myocarditis: Myth or Reality?
Arbustini, E., Narula, N., Giuliani, L., & Toro, A. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_4 · Cited by 27
Components of the Lectin Pathway of Complement in Haematologic Malignancies
Cedzyński, M., & Świerzko, A. S. (2020) · Cancers · doi:10.3390/cancers12071792 · Cited by 27
Self-citationAssociation of a new FCN3 haplotype with high ficolin-3 levels in leprosy
Andrade, F. A., Beltrame, M. H., Bini, V. B., Gonçalves, L. B., Boldt, A. B. W., & Messias-Reason, I. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005409 · Cited by 26
How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy
Caza, T. N., Al-Rabadi, L. F., & Beck, L. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.800242 · Cited by 26
van den Broek, B., van der Flier, M., de Groot, R., de Jonge, M. I., & Langereis, J. D. (2019) · Journal of Innate Immunity · doi:10.1159/000500545 · Cited by 24
Wang, Q., Huang, X., Liu, Y., Peng, Q., Zhang, Y., Liu, J., & Yuan, H. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.01.001 · Cited by 18
Review on complement analysis method and the roles of glycosaminoglycans in the complement system
Li, L., Li, Y., Ijaz, M., Shahbaz, M., Lian, Q., & Wang, F. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.08.028 · Cited by 18
Collectins and ficolins in neonatal health and disease
Cedzyński, M., & Świerzko, A. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1328658 · Cited by 16
Self-citationA new case of congenital ficolin-3 deficiency with primary immunodeficiency
Babaha, F., Abolhassani, H., Esfahani, Z. H., Yazdani, R., & Aghamohammadi, A. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1792779 · Cited by 15
Frequency and distribution of FCN2 and FCN3 functional variants among MBL2 genotypes
Bjarnadóttir, H., Arnardóttir, M., & Ludviksson, B. R. (2016) · Immunogenetics · doi:10.1007/s00251-016-0903-4 · Cited by 14
“Furthermore, the first evidence of antimicrobial activity of ficolin-3 was recently reported against the enteric commensal and opportunistic gut bacteria Hafnia alvei (Michalski et al. 2015a).”
BackgroundMethodInfluentialYou, H., & Dong, M. (2023) · Journal of International Medical Research · doi:10.1177/03000605231213781 · Cited by 12
“61 Although there is limited literature regarding direct interactions between FCN3 and HCM, Li et al. reported that FCN3 was a reliable biomarker of heart failure.”
BackgroundMistegaard, C. E., Jensen, L., Christiansen, M., Bjerre, M., Jensen, J. M. B., & Thiel, S. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00675-8 · Cited by 10
Østergaard, J. A., Sigfrids, F. J., Forsblom, C. M., Dahlström, E. H., Thorn, L. M., Harjutsalo, V., Flyvbjerg, A., Thiel, S., Hansen, T. K., & Groop, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-88352-y · Cited by 8
Man-Kupisinska, A., Michalski, M., Maciejewska, A., Świerzko, A. S., Cedzyński, M., Ługowski, C., & Łukasiewicz, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156691 · Cited by 8
Self-citationFatal pneumococcus meningitis in a child with complement factor ficolin-3 deficiency
Dadfar, E., Furuhjelm, C., Nilsson, J., Dahle, C., & Garred, P. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.07.039 · Cited by 7
Identification of signature genes and subtypes for heart failure diagnosis based on machine learning
Zhang, Y., Fan, Y., Cheng, F., Chen, D., & Zhang, H. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1492192 · Cited by 6
Mehrjooy, S., Nikbakht, R., Asl, J. M., Ghadiri, A., & Ghandil, P. (2021) · Iranian Biomedical Journal · doi:10.52547/ibj.25.6.441 · Cited by 6
“[29] who reported two cases with primary FCN3 deficiency with no severe infection.”
BackgroundMultiple-model machine learning identifies potential functional genes in dilated cardiomyopathy
Zhang, L., Lin, Y., Wang, K., Han, L., Zhang, X., Gao, X., Li, Z., Zhang, H., Zhou, J., Yu, H., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1044443 · Cited by 6
“FCN3, ficolin 3, was the most effective activator of the lectin pathway of complement (55) and more focus in rheumatic heart disease (56, 57).”
BackgroundWang, H., Chen, G., Gong, Q., Wu, J., & Chen, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403429 · Cited by 4
Osmak, G. J., & Pisklova, M. V. (2025) · Molecular Biology · doi:10.1134/s0026893324700778 · Cited by 4
Grumach, A. S., & Kirschfink, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00198-1 · Cited by 4
Lidani, K. C. F., Andrade, F. A., Beltrame, M. H., Chakravarti, I., Tizzot, M. R., Cavalcanti, E. O., Sandri, T. L., Luz, P. R., & Messias-Reason, I. (2021) · Parasite Immunology · doi:10.1111/pim.12829 · Cited by 3
Shariat, M., Heydrzadeh, M., Abolhassani, H., Bemanian, M. H., & Yazdani, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821028-4.00011-7 · Cited by 3
Computational assessment of human non-coding genetic variants with a potential clinical impact
Caron, B. (2020) · theses.fr (ABES) · doi:10.70675/e0954e55zf21cz4fddz8497z119af149cef2 · Cited by 1
Understanding the genetics underlying mastitis using a multi-pronged approach
Miles, A. M. (2019) · eCommons (Cornell University) · doi:10.7298/qq63-3f06 · Cited by 1
Brito, E. H. (2020) · Acceda (Universidad de Las Palmas de Gran Canaria)
Genster, N., & Garred, P. (2020) · Springer eBooks · doi:10.1007/978-1-4614-8678-7_8
Genster, N., & Garred, P. (2016) · Springer eBooks · doi:10.1007/978-1-4614-9209-2_8-1
Evaluation of Ficolin-3 deficiency as a risk factor in the development of rheumatic heart disease
Parker, Z., Salie, M. T., Engel, K., Zuhlke, L. J., Engel, M. E., & Spracklen, T. F. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07251-x
Análise de variantes genéticas patogênicas na Síndrome Inflamatória Multissistêmica Pediátrica
dos Reis, B. C. S. (2022) · Arca - Repositório Institucional da Fiocruz
van den Broek, B. (2026) · Radboud Repository (Radboud University)
Metadata
- Authors
- Michalski, M., Świerzko, A. S., Pągowska-Klimek, I., Niemir, Z. I., Mazerant, K., Domżalska-Popadiuk, I., Moll, M., & Cedzyński, M.
- Affiliations
- University of Łódź (PL)
- Institute for Medical Biology (PL)
- Poznan University of Medical Sciences (PL)
- Gdańsk Medical University (PL)
- Polish Mother’s Memorial Hospital Research Institute (PL)
- Corresponding author
- Świerzko, Anna St.
- ORCID
- Venue
- Immunobiology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 220
- Issue
- 6
- Pages
- 711-713
- ISSN
- 0171-2985 (ISSN-L)
- OpenAlex
- W2080990039
- Cited by
- 38
- References
- 10
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 2
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Immunobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Polish National Science Centre (N N402 353438, UMO-2011/03/B/NZ6/00052)
- European Union
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- infection susceptibility, membranous nephropathy, congenital heart disease, disease modifiers
- MeSH terms
- Glycoproteins, Humans, Immunologic Deficiency Syndromes, Infections, Genetic Predisposition to Disease, Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.